highperformr logo

Rapt Therapeutics's Overview

Total employees89
HeadquartersSouth San Francisco
Founded2015

Rapt Therapeutics is a clinical-stage immunology-based biopharmaceutical company. It focuses on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary drug discovery and development engine, Rapt Therapeutics aims to translate profound scientific insights into transformative medicines. The company is advancing a pipeline of wholly-owned drug candidates designed to modulate critical immune drivers of cancer and inflammation, with the goal of improving patients' lives.

Where is Rapt Therapeutics's Headquarters?

HQ Function

The headquarters serves as the central node for the company's research and development operations, clinical trial management, corporate strategy, finance, and administrative functions.

Notable Features:

Located within a modern biotech campus, the facility likely includes advanced laboratory spaces and an environment conducive to scientific collaboration and innovation.

Work Culture:

Rapt Therapeutics fosters a science-driven, collaborative, and patient-focused work culture. Employees are typically engaged in dynamic, cross-functional teams dedicated to advancing novel therapeutic programs.

HQ Significance:

Its location in South San Francisco provides strategic advantages, including access to a rich talent pool, proximity to leading research institutions, and opportunities for industry collaborations.

Values Reflected in HQ: The headquarters' design and functionality underscore Rapt Therapeutics's commitment to scientific rigor, innovation, and the pursuit of medical breakthroughs.

Location:

While its primary operations and headquarters are in the United States, Rapt Therapeutics has a global reach through its clinical trial activities. The company collaborates with clinical research sites and institutions in various countries to conduct studies for its drug candidates. This international approach allows for access to diverse patient populations and medical expertise, supporting the global development pathway for its innovative therapies. Core strategic, research, and corporate functions remain centralized in the U.S.

Street Address:

900 Gateway Boulevard

City:

South San Francisco

State/Province:

California

Country:

USA

Rapt Therapeutics's Global Presence

Buying Intent Signals for Rapt Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Rapt Therapeutics

As of April 2025, Rapt Therapeutics' leadership includes:

Brian Wong, M.D., Ph.D. - President & Chief Executive Officer
Jörn Drappa, M.D., Ph.D. - Chief Medical Officer
Dirk G. Brockstedt, Ph.D. - Chief Scientific Officer
Scott C. Garland - Chief Financial Officer
Andrea Van Vugt - Chief People Officer

Investors of Rapt Therapeutics

Rapt Therapeutics has been backed by several prominent investors over the years, including:

The Column Group
Kleiner Perkins
GV (Google Ventures)
Topspin Partners
Celgene (now part of Bristol Myers Squibb)
Various public market institutional investors (e.g., BlackRock, Vanguard, Perceptive Advisors)

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

In the past 12 months, Rapt Therapeutics has strengthened its leadership team with key appointments, including a new Chief Financial Officer and a new Chief People Officer. The company also saw the departure of its Chief Business Officer.

Departures

Shawn M. Leland, Pharm.D., R.Ph., Shawn M. Leland resigned from his position as Chief Business Officer to pursue other opportunities.

New Appointments:

Scott C. Garland, Scott C. Garland appointed as Chief Financial Officer.
Andrea Van Vugt, Andrea Van Vugt appointed as Chief People Officer.

Technology (Tech Stack) used by Rapt Therapeutics

Discover the tools Rapt Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Rapt Therapeutics Email Formats and Examples

Rapt Therapeutics commonly uses the email format combining the first initial of an employee's first name with their full last name, followed by @rapt.com.

[first_initial][last_name]@rapt.com

Format

bwong@rapt.com

Example

75%

Success rate

News and media

GlobeNewswireMarch 18, 2024

RAPT Therapeutics Provides Update on Phase 2b Trial for Zelnecirnon in Atopic Dermatitis and Phase 2a Trial in Asthma

Rapt Therapeutics provided an update on its Phase 2b clinical trial of zelnecirnon (RPT193) in patients with moderate-to-severe atopic dermatitis (AD) and its Phase 2a trial in patients with eosinophilic asthma. The company decided to continue the AD trial and discontinue the asthma trial based on an interim futility analysis....more

GlobeNewswireFebruary 27, 2024

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress

Rapt Therapeutics announced its financial results for the fourth quarter and full year ended December 31, 2023. The company also highlighted recent progress in its clinical programs and corporate development....more

GlobeNewswireNovember 20, 2023

RAPT Therapeutics Announces FDA Clearance of IND Application for Tivumecirnon (RPT319) in Hematologic Malignancies

Rapt Therapeutics announced that the U.S. Food and Drug Administration (FDA) cleared its Investigational New Drug (IND) application for tivumecirnon (RPT319), a CCR4 antagonist, for a Phase 1/2 clinical trial in patients with hematologic malignancies....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Rapt Therapeutics, are just a search away.